H.R. 5160: Stem Cell Therapeutic and Research Reauthorization Act of 2025

H.R. 5160 is a federal bill in the 119th Congress. The Stem Cell Therapeutic and Research Reauthorization Act of 2025 reauthorizes the legal framework for federal bone marrow and umbilical cord blood transplantation programs through fiscal year 2031. This legislation sets the spending ceilings and legal… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.